Troy C Quigg
Overview
Explore the profile of Troy C Quigg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bender J, Damodharan S, Capitini C, Moskop A, Toner K, Vatsayan A, et al.
Blood Adv
. 2024 Jun;
8(15):4164-4168.
PMID: 38916857
No abstract available.
2.
Zinter M, Dvorak C, Mayday M, Reyes G, Simon M, Pearce E, et al.
Nat Med
. 2024 May;
30(7):1982-1993.
PMID: 38783139
Hematopoietic cell transplantation (HCT) uses cytotoxic chemotherapy and/or radiation followed by intravenous infusion of stem cells to cure malignancies, bone marrow failure and inborn errors of immunity, hemoglobin and metabolism....
3.
Keller M, Hanley P, Chi Y, Aguayo-Hiraldo P, Dvorak C, Verneris M, et al.
Nat Commun
. 2024 Apr;
15(1):3258.
PMID: 38637498
Viral infections remain a major risk in immunocompromised pediatric patients, and virus-specific T cell (VST) therapy has been successful for treatment of refractory viral infections in prior studies. We performed...
4.
Zinter M, Dvorak C, Mayday M, Reyes G, Simon M, Pearce E, et al.
medRxiv
. 2023 Dec;
PMID: 38077035
Lung injury is a major determinant of survival after pediatric hematopoietic cell transplantation (HCT). A deeper understanding of the relationship between pulmonary microbes, immunity, and the lung epithelium is needed...
5.
Eylon M, Prabhu S, John S, King M, Bhatt D, Curran K, et al.
Front Immunol
. 2023 Nov;
14:1239132.
PMID: 37965315
Introduction: Mediport use as a clinical option for the administration of chimeric antigen receptor T cell (CAR T cell) therapy in patients with B-cell malignancies has yet to be standardized....
6.
Thakar M, Logan B, Puck J, Dunn E, Buckley R, Cowan M, et al.
Lancet
. 2023 Jun;
402(10396):129-140.
PMID: 37352885
Background: Severe combined immunodeficiency (SCID) is fatal unless durable adaptive immunity is established, most commonly through allogeneic haematopoietic cell transplantation (HCT). The Primary Immune Deficiency Treatment Consortium (PIDTC) explored factors...
7.
Svec P, Elfeky R, Galimard J, Higham C, Dalissier A, Quigg T, et al.
Bone Marrow Transplant
. 2022 Nov;
58(2):129-141.
PMID: 36333550
Terminal complement blockade by humanised monoclonal antibody eculizumab has been used to treat transplantation-associated thrombotic microangiopathy (TA-TMA) in recent years. This retrospective international study conducted by the Paediatric Diseases (PDWP)...
8.
Cuvelier G, Logan B, Prockop S, Buckley R, Kuo C, Griffith L, et al.
Blood
. 2022 Jun;
140(7):685-705.
PMID: 35671392
Adenosine deaminase (ADA) deficiency causes ∼13% of cases of severe combined immune deficiency (SCID). Treatments include enzyme replacement therapy (ERT), hematopoietic cell transplant (HCT), and gene therapy (GT). We evaluated...
9.
Rattani N, Matheny C, Eckrich M, Madden L, Quigg T
Cancer Rep (Hoboken)
. 2021 May;
5(1):e1403.
PMID: 33932151
Background: Parvovirus B19 (PVB19) infection has been implicated in allograft failure or dysfunction in solid organ transplantation (SOT) and allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the literature is limited....
10.
Dorsey M, Wright N, Chaimowitz N, Davila Saldana B, Miller H, Keller M, et al.
J Clin Immunol
. 2020 Dec;
41(2):498-500.
PMID: 33274413
No abstract available.